239
Views
17
CrossRef citations to date
0
Altmetric
Original Research

In vitro activity of cefoperazone and cefoperazone-sulbactam against carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa

, , , &
Pages 25-29 | Published online: 20 Dec 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Leilei Wang, Yuancheng Chen, Renru Han, Zhiwei Huang, Xuefei Zhang, Fupin Hu & Fan Yang. (2021) Sulbactam Enhances in vitro Activity of β-Lactam Antibiotics Against Acinetobacter baumannii. Infection and Drug Resistance 14, pages 3971-3977.
Read now
Chia-Hung Chen, Chih-Yen Tu, Wei-Chih Chen, Li-Kuo Kuo, Yao-Tung Wang, Pin-Kuei Fu, Shih-Chi Ku, Wen-Feng Fang, Chin-Ming Chen & Chih-Cheng Lai. (2021) Clinical Efficacy of Cefoperazone-Sulbactam versus Piperacillin-Tazobactam in the Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia. Infection and Drug Resistance 14, pages 2251-2258.
Read now

Articles from other publishers (15)

Haiyang Liu, Xiaochen Liu, Jintao He, Linghong Zhang, Feng Zhao, Zhihui Zhou, Xiaoting Hua & Yunsong Yu. (2023) Emergence and Evolution of OXA-23-Producing ST46Pas-ST462Oxf-KL28-OCL1 Carbapenem-Resistant Acinetobacter baumannii Mediated by a Novel ISAba1-Based Tn7534 Transposon. Antibiotics 12:2, pages 396.
Crossref
Shang-Yi Lin, Po-Liang Lu, Ting-Shu Wu, Shian-Sen Shie, Feng-Yee Chang, Ya-Sung Yang, Tsung-Ta Chiang, Fu-Der Wang, Mao-Wang Ho, Chia-Hui Chou, Jien-Wei Liu, Zhi-Yuan Shi, Yin-Ching Chuang & Hung-Jen Tang. (2022) Correlation Between Cefoperazone/Sulbactam MIC Values and Clinical Outcomes of Escherichia coli Bacteremia. Infectious Diseases and Therapy 11:5, pages 1853-1867.
Crossref
Chien-Ming Chao, Chih-Cheng Lai, Chen-Hsiang Lee & Hung-Jen Tang. (2022) Optimal Dose of Cefoperazone-Sulbactam for Acute Bacterial Infection in Patients with Chronic Kidney Disease. Antibiotics 11:5, pages 610.
Crossref
Chien-Hsiang Tai, Hung-Jen Tang & Chen-Hsiang Lee. (2022) Clinical Outcomes and Adverse Effects in Septic Patients with Impaired Renal Function Who Received Different Dosages of Cefoperazone–Sulbactam. Antibiotics 11:4, pages 460.
Crossref
Linhu Ye, Lei Cheng, Lingti Kong, Xinqian Zhao, Guoyan Xie, Jing He, Hong Liu, Yan Deng, Xinyu Wu, Tingting Wang & Xixiao Yang. (2022) Pharmacokinetic and pharmacodynamic analysis of cefoperazone/sulbactam for the treatment of pediatric sepsis by Monte Carlo simulation. Analytical Methods 14:11, pages 1148-1154.
Crossref
Zaihui Peng, Xiaochun Zhang, Long Yuan, Ting Li, Yajie Chen, Hao Tian, Dandan Ma, Jun Deng, Xiaowei Qi & Xuntao Yin. (2021) Integrated endotoxin-adsorption and antibacterial properties of platelet-membrane-coated copper silicate hollow microspheres for wound healing. Journal of Nanobiotechnology 19:1.
Crossref
Shayan Chen, Jiyu Shi, Minghui Chen, Jun Ma, Zhaowei Zeng, Rui Wang, Yunfeng Cui & Xue Gao. (2021) Characteristics of and risk factors for biliary pathogen infection in patients with acute pancreatitis. BMC Microbiology 21:1.
Crossref
Hongbin Wu, Heqiang Feng, Lijie He, Heping Zhang & Ping Xu. (2021) In Vitro Activities of Tigecycline in Combination with Amikacin or Colistin Against Carbapenem-Resistant Acinetobacter baumannii. Applied Biochemistry and Biotechnology 193:12, pages 3867-3876.
Crossref
Shao-Huan LanChien-Ming ChaoShen-Peng ChangLi-Chin LuChih-Cheng Lai. (2021) Clinical Efficacy and Safety of Cefoperazone–Sulbactam in Treatment of Intra-Abdominal Infections: A Systematic Review and Meta-Analysis. Surgical Infections 22:8, pages 763-770.
Crossref
Yee-Huang Ku & Wen-Liang Yu. (2021) Cefoperazone/sulbactam: New composites against multiresistant gram negative bacteria?. Infection, Genetics and Evolution 88, pages 104707.
Crossref
Ning Fan, Yong Hu, Hong Shen, Shengjie Liu, Guang Zhao, Lanju Sun, Chunyan Li, Xin Zhao, Yanning Li, Jianhua Wang & Yunfeng Cui. (2020) Compositional and drug-resistance profiling of pathogens in patients with severe acute pancreatitis: a retrospective study. BMC Gastroenterology 20:1.
Crossref
Siva R. Uppalapati, Abhiroop Sett & Ranjana Pathania. (2020) The Outer Membrane Proteins OmpA, CarO, and OprD of Acinetobacter baumannii Confer a Two-Pronged Defense in Facilitating Its Success as a Potent Human Pathogen. Frontiers in Microbiology 11.
Crossref
Jean-Francois Jabbour, Sima L. Sharara & Souha S. Kanj. (2020) Treatment of multidrug-resistant Gram-negative skin and soft tissue infections. Current Opinion in Infectious Diseases 33:2, pages 146-154.
Crossref
Ming-Jen Sheu, Chi-Chung Chen, Ying-Chen Lu, Bo-An Su, Chun-Cheng Zhang, Shu-Shen Wang, Yin-Ching Chuang, Hung-Jen Tang & Chih-Cheng Lai. (2020) In Vitro Antimicrobial Activity of Various Cefoperazone/Sulbactam Products. Antibiotics 9:2, pages 77.
Crossref
Shao-Huan Lan, Shen-Peng Chang, Chih-Cheng Lai, Li-Chin Lu & Hung-Jen Tang. (2020) Efficacy and safety of cefoperazone-sulbactam in empiric therapy for febrile neutropenia. Medicine 99:8, pages e19321.
Crossref